Potassium-Hydroxypentyl Benzoate

Potassium-hydroxypentyl benzoate is in phase II clinical trials for the treatment of acute ischemic stroke (AIS).

The compound was co-developed by Institute of Materia Medica, Chinese Academy of Medical Science and Yunnan Biovalley Pharmaceutical.

Index：

General Information

Update Date：2016-02-15

Drug Name：
Potassium-Hydroxypentyl Benzoate
Research Code：
dl-PHPB
Trade Name：
MOA：
Unknown
Indication：
Acute ischemic stroke (AIS)
Status：
Phase II (Active)
Company：
云南生物谷药业 (Originator), 中国医学科学院药物研究所 (Originator)
Sales：
ATC Code：
Chemical Structure

Update Date：2016-02-26

Molecular Weight 246.34
Formula C12H15O3 • K
CAS No. 380905-48-6 (2- (1-Hydroxypentyl)benzoic acid);
685886-82-2 (dl-PHPB);
Chemical Name Benzoic acid, 2-(1-hydroxypentyl)-, potassium salt (1:1)
2-(1-Hydroxypentyl)benzoic acid （Free Acid/Base）Parameters：
MW HD HA FRB* PSA* cLogP*
208.25 2 3 6 57.5 2.053±0.237
*：Calculated by ACD/Labs software V11.02.